Anika Therapeutics, Inc. (ANIK) Operating income 2016–2025
Anika Therapeutics, Inc. (ANIK) annual operating income history from SEC filings — each fiscal year as reported.
-$11.1MFY2025 · since FY2016: $50.6M → -$11.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.1M | -116.6% |
| FY2024 | -$5.1M | -704.4% |
| FY2023 | $844,000 | -77.0% |
| FY2022 | $3.7M | +40.3% |
| FY2021 | $2.6M | +109.2% |
| FY2020 | -$28.3M | -182.7% |
| FY2019 | $34.2M | +57.5% |
| FY2018 | $21.7M | -52.4% |
| FY2017 | $45.7M | -9.6% |
| FY2016 | $50.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice